2016 Pediatric Flu

Awarded Award Notice Posted

Solicitation number
2016-N-17632
Agency
CDC Office of Acquisition Services Centers for Disease Control and Prevention, Department of Health and Human Services
Awarded
Set-aside
No set-aside

Opportunity facts

Contract number
200-2016-88487
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
Not on record
Place of performance
Conus, United States

Notice details come from SAM.gov. Updated .

Notice text

2 versions

Update #2 · Latest ·

Added: Jul 07, 2016 1:48 pm This is a notification of intention to increase the target quantities for select vaccines on four contracts. Please see the atttached documents listing the details for each of the four contracts. 

Update #1 ·

Added: Aug 26, 2015 11:53 am The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite quantity, indefinite delivery contracts for the purchase of the following pediatric vaccines and estimated quantities manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration:

Item Descriptions & Quantities


1. Influenza Vaccine
Pediatric (Age 6 months and older)
Fed. Excise Tax: $0.75 per dose
Maximum: 6 Million doses
Minimum: 100 doses


2. Influenza Vaccine
Pediatric (Age 6-35 months)
Fed. Excise Tax: $0.75 per dose
Maximum: 9 Million doses
Minimum: 100 doses


3. Influenza Vaccine
Pediatric (Age 36 months and older)
Fed. Excise Tax: $0.75 per dose
Maximum: 6 Million doses
Minimum: 100 doses



4. Influenza Vaccine
Pediatric (Age 4 years and older)
Fed. Excise Tax: $0.75 per dose
Maximum: 1.5 Million doses
Minimum: 100 doses


5. Influenza Vaccine
Pediatrics; Live virus, intranasal (Age 2-49 years)
Fed. Excise Tax: $0.75 per dose
Maximum: 12 Million doses
Minimum: 100 doses


The vaccines awarded under the resulting contracts will be purchased for NCIRD's immunization awardees (the fifty state health departments, several large city program and current and former U.S. Territories) to support pediatric immunization programs as provided under Section 317(j) of the Public Health Service Act and Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA '93). Vaccines shall be delivered F.O.B. Destination to the 50 states and U.S. territories. The period of performance shall be 12 months from date of award. This acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Items in conjunction with FAR Part 13. The solicitation and any amendments issued will be posted on www.fedbizopps.gov when issued. No hard copies of the solicitation and amendments will be mailed. Please note Funds are not currently available for the award. This solicitation is subject of funds availability during FY 2015. Any questions regarding this notice shall be submitted in writing ONLY to Michael Harwell at wyu4@cdc.gov. Telephone inquiries will not be honored.

Attachments

Files attached to this notice, newest first
File Type Posted
Novartis_FBO_Posting.docx DOCX document
Sanofi_FBO_Posting.docx DOCX document
GSK_FBO_Posting.docx DOCX document
Seqirus_FBO_Posting.docx DOCX document
Ped_Flu_1449.doc DOC document

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity